Given the title of yesterday’s Market Musings piece and the subject of today’s, you, dear reader, could be forgiven for thinking that I have some kind of a drug problem. I can assure you that I don’t. I just have a problem with some drug stocks, both the non-conventional and more traditional. In yesterday’s piece I laid out my reasons for being bearish on the long term prospects for the manufacturers and suppliers of pharmaceuticals. Today it is the more controversial cannabis related stocks that have gained my attention.